Athenahealth was Downgraded to a Hold Rating at Cowen & Co.

By Jason Carr

In a report released today, Charles Rhyee from Cowen & Co. downgraded Athenahealth (NASDAQ: ATHN) to Hold. The company’s shares closed on Friday at $139.93.

According to, Rhyee is a 4-star analyst with an average return of 6.8% and a 58.7% success rate. Rhyee covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, AmerisourceBergen, and Diplomat Pharmacy.

Currently, the analyst consensus on Athenahealth is Moderate Buy and the average price target is $143.40, representing a 2.5% upside.

In a report issued on July 19, J.P. Morgan also maintained a Hold rating on the stock with a $136 price target.

The company has a one year high of $158.66 and a one year low of $90.11. Currently, Athenahealth has an average volume of 691.6K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

athenahealth, Inc. provides cloud-based business services and mobile applications for medical groups and health systems. It also provides ongoing billing, clinical-related, and other related services to customers. The company offers practice management and electronic health record services.